Elypta
Elypta is a molecular diagnostic company focused on preventing cancer mortality by developing a liquid biopsy platform for early detection and monitoring of the disease. The approach is based on measurement of 19 biomarkers and use of machine learning algorithms to generate a score against cancer-type specific signatures.